Advanced search
Publication Cover
Leukemia & Lymphoma Volume 25, 1997 - Issue 5-6
Submit an article Journal homepage
27
Views
5
CrossRef citations to date
0
Altmetric
Original Article

A Phase I Study of Interleukin-6 After Autologous Bone Marrow Transplantation for Patients with Poor Prognosis Hodgkin's Disease

K. R. Imrie The University of Toronto Autologous Blood and Marrow Transplant Program, Toronto; Sunnybrook Health Sciences Centre, 2075 Bay view Ave., Room A240, TorontoCorrespondence[email protected]
,
B. Sheridan Sunnybrook Health Sciences Centre, 2075 Bay view Ave., Room A240, Toronto
,
R. Colwill The University of Toronto Autologous Blood and Marrow Transplant Program, Toronto
,
M. Crump The University of Toronto Autologous Blood and Marrow Transplant Program, Toronto
,
A. K. Stewart The University of Toronto Autologous Blood and Marrow Transplant Program, Toronto
,
J. McCrae The University of Toronto Autologous Blood and Marrow Transplant Program, Toronto
,
R. Danish The University of Toronto Autologous Blood and Marrow Transplant Program, Toronto
,
D. Sutton The University of Toronto Autologous Blood and Marrow Transplant Program, Toronto
,
F. Romeyer Sandoz Canada, Montreal, Canada
&
A. Keating The University of Toronto Autologous Blood and Marrow Transplant Program, Toronto
 show all
Pages 555-563 | Received 20 Jul 1996, Published online: 01 Jul 2009

References

  • Van Snick J. Interleukin‐6: an overview. Annual Review of Immunology 1990; 8: 253–278
  • Lotz M. Interleukin‐6. Cancer Investigation 1993; 11(6)732–742
  • Caracciolo D., Clark S. C., Rovera G. Human interleukin‐6 supports granulocytic differentiation of hematopoietic progenitor cells and acts synergistically with GM‐CSF. Blood 1989; 73: 666
  • Ishibashi T., Kimura H., Uchida T., Kariyone S., Friese P., Burstein S. A. Human Interleukin‐6 is a direct promotor of maturation of megakaryocytes in vitro. Proceedings of the National Academy of Sciences 1989; 86: 5953–5957
  • Suda T., Yamaguchi Y., Suda J., Miura Y., Okano A., Akiyama Y. Effect of lnterleukin‐6 on the differentiation and proliferation of murine and human hematopoietic progenitors. Experimental Hematology 1988; 16: 891
  • Ptachen M. L., Macvittie T. J., Williams J. L., Schwatz G. N., Souza L. M. Administration of Interleukin‐6 stimulates multilineage hematopoiesis and accelerates recovery from radiation‐induced hematopoietic depression. Blood 1991; 77: 472–480
  • Okano A., Suzuki C., Takatsuki F., et al. Effects of Interleukin‐6 on hematopoiesis in bone marrow transplanted mice. Transplantation 1989; 47: 738
  • Givon T., Slavin S. Potential use of Interleukin‐6 after syngeneic and semiallogeneic bone marrow transplantation in mice. Blood 1994; 83(6)1690–1697
  • Herodin F., Mestries J., Janodet D., et al. Recombinant glycosylated human interleukin‐6 accelerates peripheral blood platelet count recovery in radiation‐induced bone marrow depression in baboons. Blood 1992; 80(3)688–695
  • Asano S., Okano A., Ozawa K., et al. In vivo effects of recombinant human interleukin‐6 in primates: stimulated production of platelets. Blood 1990; 75(8)1602–1605
  • Weber J., Yang J. C., Topalian S. L., et al. Phase I trial of Subcutaneous Interleukin‐6 in patients with advanced malignancies. Journal of Clinical Oncology 1993; 11(3)499–506
  • Kishimoto T. The biology of Interleukin‐6. Blood 1989; 74: 1–10
  • Mule J. J., McLntosh J. A., Jablons D. M. In vivo administration of recombinant lnterleukin‐6 mediates tumor regression in mice. Journal of Experimental Medicine 1990; 171: 629–637
  • Chen L., Ziberstein A., Revel M. Growth inhibition of breast carcinoma and leukemia/lymphoma cell lines by recombinant Interferon‐B2. Proceedings of the National Academy of Sciences 1988; 85: 8037–8041
  • Shabo Y., Lotem J., Rubenstein M., et al. The myeloid blood cell differentiation‐inducing protein MGI‐2A is Interleukin‐6. Blood 1988; 72: 2070–2073
  • Goldstone A. H., McMillan A. K. The place of high‐dose therapy with hematopoietic stem cell transplantation in relapsed and refractory hodgkin's disease. Annals of Oncology 1993; 4(Suppl 1)21
  • Crump M., Smith A., Brandwein J., et al. High‐dose etoposide and melphalan, autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant. Journal of Clinical Oncology 1993; 11(4)704–711
  • Prince H. M., Crump M., Imrie K., et al. Intensive therapy and autotransplant for patients with an incomplete response to front‐line therapy for lymphoma. Annals of Oncology 1996; 7: 1043–1049
  • Miller A. B. WHO Toxicity Scale. Cancer 1981; 47: 210
  • Du X. X., Williams D. A. Interleukin‐11: a multifunctional growth factor derived from the hematopoietic microenvironment. Blood 1994; 83(8)2023–2030
  • Du X. X., Doerschuk C. M., Orazi A., Williams D. A. Bone marrow stromal derived growth factor, Interleukin‐11. stimulates recovery of small intestinal mucosal cells following cytoablative therapy. Blood 1994; 83: 33
  • Dofferhoff A. S., Bom V. J., Van Ingen J. Patterns of cytokines, plasma endotoxin, and acute phase proteins during the treatment of severe sepsis in humans. Progress in Clinical and Biologic Research 1991; 43: 367
  • Hack C. E., De Groot E. R., Felt‐Bersma R. J., et al. Increased plasma levels of Interleukin‐6 in sepsis. Blood 1989; 74: 1704–1710
  • Chasty R. C., Lamb W. R., Gallati H., Roberts T. E., Brenchley P. E., Yin J. A. Serum cytokine levels in patients undergoing bone marrow transplantation. Bone Marrow Transplantation 1993; 12(4)331
  • Kawano Y., Takaue Y., Saito S., et al. Granulocyte colony stimulating factor (CSF), macrophage‐CSF, granulocyte macrophage CSF, interleukin‐3, and interleukin‐6 levels in sera from patients undergoing blood stem cell autografts. Blood 1993; 81: 856–860
  • Baiocchi G., Scambia G., Benedetti P., et al. Autologous stem cell transplantation: Sequential production of hematopoietic cytokines underlying granulocytic recovery. Cancer Research 1993; 53: 1297–1303

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.